SIOX NASDAQ
Sio Gene Therapies Inc.
1W: +22.9%
1M: +22.9%
3M: +21.0%
1Y: +4.9%
3Y: -83.5%
5Y: -94.9%
$0.48
Last traded 2024-02-07 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$75M
-44.4% ▼
5Y CAGR: -19.5%
Total Liabilities
$15M
+25.1% ▲
5Y CAGR: -31.5%
Shareholders Equity
$60M
-51.1% ▼
5Y CAGR: -13.5%
Cash & Investments
$64M
-46.4% ▼
5Y CAGR: -21.4%
Total Debt
$3M
+102.4% ▲
5Y CAGR: -45.3%
Net Debt
-$61M
+48.0% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $154M | $107M | $81M | $119M | $64M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $154M | $107M | $81M | $119M | $64M |
| Net Receivables | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $4M | $8M | $5M | $13M | $8M |
| Total Current Assets | $158M | $115M | $85M | $132M | $72M |
| Property, Plant & Equip. | $3M | $1M | $2M | $2M | $3M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $6M | $6M | $0 | $0 |
| Other Non-Current Assets | $0 | $973K | $46K | $1M | $0 |
| Total Non-Current Assets | $3M | $8M | $8M | $3M | $3M |
| Total Assets | $161M | $123M | $94M | $135M | $75M |
| — Liabilities — | |||||
| Accounts Payable | $4M | $2M | $4M | $1M | $4M |
| Short-Term Debt | $10M | $21M | $16M | $311K | $786K |
| Deferred Revenue | -$10M | -$21M | $0 | $0 | $0 |
| Other Current Liabilities | $33M | $21M | $11M | $9M | $8M |
| Total Current Liabilities | $47M | $43M | $32M | $11M | $13M |
| Long-Term Debt | $43M | $23M | $79K | $932K | $2M |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $43M | $23M | $79K | $932K | $2M |
| Total Liabilities | $90M | $66M | $32M | $12M | $15M |
| — Equity — | |||||
| Common Stock | $1K | $0 | $0 | $1K | $1K |
| Retained Earnings | -$557M | -$686M | -$759M | -$791M | -$863M |
| Accumulated OCI | $126K | $911K | -$55K | $335K | $337K |
| Total Stockholders Equity | $71M | $56M | $62M | $123M | $60M |
| Total Liabilities & Equity | $161M | $123M | $94M | $135M | $75M |
| — Key Metrics — | |||||
| Total Debt | $53M | $44M | $16M | $1M | $3M |
| Net Debt | -$102M | -$63M | -$64M | -$118M | -$61M |
| Total Investments | $0 | $6M | $6M | $0 | $0 |